These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32673902)

  • 1. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
    Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of 5-HT
    Jankowska A; Satała G; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Głuch-Lutwin M; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Future Med Chem; 2021 Sep; 13(18):1497-1514. PubMed ID: 34253032
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
    Chłoń-Rzepa G; Ślusarczyk M; Jankowska A; Gawalska A; Bucki A; Kołaczkowski M; Świerczek A; Pociecha K; Wyska E; Zygmunt M; Kazek G; Sałat K; Pawłowski M
    Eur J Med Chem; 2018 Oct; 158():517-533. PubMed ID: 30245393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
    Gu ZS; Xiao Y; Zhang QW; Li JQ
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
    Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
    Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
    Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT
    Chłoń-Rzepa G; Zagórska A; Żmudzki P; Bucki A; Kołaczkowski M; Partyka A; Wesołowska A; Kazek G; Głuch-Lutwin M; Siwek A; Starowicz G; Pawłowski M
    Arch Pharm (Weinheim); 2016 Dec; 349(12):889-903. PubMed ID: 27869315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
    Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
    Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
    Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
    Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
    Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
    Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
    Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.
    Gewald R; Grunwald C; Egerland U
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4308-14. PubMed ID: 23806553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.